Carbapenem resistance: a review
FS Codjoe, ES Donkor - Medical Sciences, 2017 - mdpi.com
Carbapenem resistance is a major and an on-going public health problem globally. It occurs
mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas …
mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas …
[HTML][HTML] Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Although the rapid spread of carbapenemase-producing Gram-negatives (CPGNs) is
providing the scientific community with a great deal of information about the molecular …
providing the scientific community with a great deal of information about the molecular …
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii
We investigated the mechanisms of resistance to carbapenems, aminoglycosides,
glycylcyclines, tetracyclines, and quinolones in 90 multiresistant clinical strains of …
glycylcyclines, tetracyclines, and quinolones in 90 multiresistant clinical strains of …
Multiresistant Acinetobacter baumannii infections: epidemiology and management
J Garnacho-Montero… - Current opinion in …, 2010 - journals.lww.com
The optimal treatment for multidrug-resistant A. baumannii nosocomial infections has not
been established. Carbapenems are the mainstay of treatment in susceptible isolates …
been established. Carbapenems are the mainstay of treatment in susceptible isolates …
Global Spread of Drug-Resistant Acinetobacter Baumannii: Molecular Epidemiology And Management Of Antimicrobial Resistance
E Durante-Mangoni, R Zarrilli - Future microbiology, 2011 - Taylor & Francis
Acinetobacter baumannii is an opportunistic Gram-negative pathogen with increasing
relevance in a variety of hospital-acquired infections especially among intensive care unit …
relevance in a variety of hospital-acquired infections especially among intensive care unit …
Carbapenems
D Breilh, J Texier-Maugein, B Allaouchiche… - Journal of …, 2013 - Taylor & Francis
Objective: To assess the relative strengths and weaknesses of carbapenems by considering
their microbiological, clinical, pharmacokinetics and pharmacokinetic/pharmacodynamic …
their microbiological, clinical, pharmacokinetics and pharmacokinetic/pharmacodynamic …
Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management
A Sandiumenge, J Rello - Current opinion in pulmonary medicine, 2012 - journals.lww.com
Ventilator-associated pneumonia caused by ESKAPE organisms:... : Current Opinion in
Pulmonary Medicine Ventilator-associated pneumonia caused by ESKAPE organisms: cause …
Pulmonary Medicine Ventilator-associated pneumonia caused by ESKAPE organisms: cause …
Los carbapenems disponibles: propiedades y diferencias
MJF Martínez, MIG García, EG Sánchez… - … y microbiología clínica, 2010 - Elsevier
Los carbapenems son los antibióticos β-lactámicos dotados de mayor espectro, actividad y
resistencia a las β-lactamasas. Por sus cualidades son imprescindibles en el tratamiento …
resistencia a las β-lactamasas. Por sus cualidades son imprescindibles en el tratamiento …
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.
M Castanheira, RN Jones, DM Livermore - Diagnostic microbiology and …, 2009 - Elsevier
The in vitro activity of doripenem against prevalent nonfermentative Gram-negative bacilli
and Aeromonas spp. was evaluated. The collection comprised 15 236 nonduplicate clinical …
and Aeromonas spp. was evaluated. The collection comprised 15 236 nonduplicate clinical …
In Vitro Activity of Doripenem in Combination with Various Antimicrobials Against Multidrug-Resistant Acinetobacter baumannii: Possible Options for the Treatment of …
L Principe, A Capone, A Mazzarelli… - Microbial Drug …, 2013 - liebertpub.com
Aims: The aim of this study was to evaluate the in vitro activity of doripenem (DOR) alone
and in combination with a variety of commonly used anti-Acinetobacter chemotherapeutic …
and in combination with a variety of commonly used anti-Acinetobacter chemotherapeutic …